SLDB FY 2020 Earnings — Solid Biosciences Inc. Revenue & Financial Results | Market Cap Arena

SLDBSolid Biosciences Inc.

$581M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$4M

Operating Income

-$86M

Net Income

-$88M

EPS (Diluted)

$-25.50

Cash Flow

Operating Cash Flow

-$57M

Free Cash Flow

-$57M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$171M

Total Liabilities

$39M

Stockholders' Equity

$132M

Cash & Equivalents

$155M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$4M	-$3M	-38.9%
Operating Income	-$86M	-$119M	+27.5%
Net Income	-$88M	-$117M	+24.7%